Small Molecules
- Berbamine Derivatives for the Treatment of Cancer MK+10-033-Berbamine-Derivatives-for-the-Treatment-of-Cancer
- CpG Delivered Using Carbon Nanotubes to Treat Brain Cancer MK+12-087-CpG-Delivered-Using-Carbon-Nanotubes-to-Treat-Brain-Cancer
- Diagnosis and Treatment of 12-Lipoxygenase-Related Diseases
- Improved Mass Spectrometry for Analyzing Catechol Estrogen Varieties MK+12-102-Improved-Mass-Spectrometry-for-Analyzing-Catechol-Estrogen-Varieties
- Isatin Derivatives for the Treatment of Cancer MK+12-086-Isatin-Derivatives-for-the-Treatment-of-Cancer
- Novel Compound for Treating Cancer MK+11-078-Novel-Compound-for-Treating-Cancer
- Novel Synthesis of Alkylated Bile Acids MK11-067-Novel-Synthesis-of-Alkylated-Bile-Acids
- Preventing Inflammation by Inhibiting Cox-2 Gene Transcription MK+10-007-Preventing-Inflammation-by-Inhibiting-Cox-2-Gene-Transcription
- Ribonucleotide Reductase Inhibitors for the Treatment of Cancer MK+10-032-Ribonucleotide-Reductase-Inhibitors-for-the-Treatment-of-Cancer
- Small Molecule Therapeutics for Complications of Diabetes MK+10-038-Small-Molecule-Therapeutics-for-Complications-of-Diabetes
- Synthesis of Grossularines-1 and Analogs to Treat Cancer MK+10-031-Synthesis-of-Grossularines-1-and-Analogs-to-Treat-Cancer
- Treating Chemoresistance in Chronic Myelogenous Leukemia MK+10-035-Treating-Chemoresistance-in-Chronic-Myelogenous-Leukemia
- Treating Liposarcomas Using HIV Protease Inhibitors MK+10-039-Treating-Liposarcoma- Using-HIV-Protease-Inhibitors